Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00465972Phase 4Completed
Phase 4, randomised, double-blind trial in Insomnia comparing Placebo, Doxepin and Temazepam (3 arms). Primary endpoint: Insomnia Severity Rating Scale at 3 months. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00465972.